Login / Signup

Vitreal Concentrations of Vascular Endothelial Growth Factor in Patients with Rhegmatogenous Retinal Detachment.

Hossein HasanpourMaria Cristina KenneyBaruch D KuppermannMohammad Riazi EsfahaniMozhgan Rezaei KanaviMithalesh Kumar SinghMasoud Soheilian
Published in: Journal of clinical medicine (2023)
The purpose of this study is to evaluate the concentration of vascular endothelial growth factor (VEGF) in the vitreous humor of patients with primary rhegmatogenous retinal detachment (RRD). This is a prospective case control study. Eighteen patients with primary RRD without proliferative vitreoretinopathy C (PVR C) were enrolled as cases, and twenty-two non-diabetic retinopathy patients who were candidates for complete pars plana vitrectomy due to Macular Hole or Epiretinal Membrane were included as the control group. Undiluted vitreal samples were collected during the initiation of Pars Plana Vitrectomy (PPV) prior to any infusion into the posterior cavity. Vitreous samples were also collected from 21 fresh cadaveric globes. The vitreous concentration of VEGF was measured by enzyme-linked immunosorbent assay (ELISA) technique and compared between these two groups. The vitreal concentration of VEGF was 0.643 ± 0.088 ng/mL in the RRD group. Measured concentrations of VEGF in controls were 0.043 ± 0.104 ng/mL, and in cadaveric eyes they were 0.033 ± 0.058 ng/mL. The mean VEGF concentration in the RRD group was statistically higher than in the control group ( p < 0.0001) and cadaveric eyes ( p < 0.0001). Our study shows that vitreal VEGF concentrations significantly increase in patients with RRD.
Keyphrases
  • vascular endothelial growth factor
  • diabetic retinopathy
  • optical coherence tomography
  • endothelial cells
  • ultrasound guided
  • low dose
  • high throughput
  • single cell